These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27283171)

  • 1. The Relevance of Hereditary Cancer Risks to Precision Oncology: What Should Providers Consider When Conducting Tumor Genomic Profiling?
    Jain R; Savage MJ; Forman AD; Mukherji R; Hall MJ
    J Natl Compr Canc Netw; 2016 Jun; 14(6):795-806. PubMed ID: 27283171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic profiling in oncology clinical practice.
    Rodríguez N; Viñal D; Rodríguez-Cobos J; De Castro J; Domínguez G
    Clin Transl Oncol; 2020 Sep; 22(9):1430-1439. PubMed ID: 31981077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding perceptions of tumor genomic profile testing in Black/African American cancer patients in a qualitative study: the role of medical mistrust, provider communication, and family support.
    Luck CC; Bass SB; Chertock Y; Kelly PJA; Singley K; Hoadley A; Hall MJ
    J Community Genet; 2024 Jun; 15(3):281-292. PubMed ID: 38366313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologists' perceptions of tumor genomic profiling and barriers to communicating secondary hereditary risks to African American cancer patients.
    Hall MJ; D'Avanzo PA; Chertock Y; Kelly PJA; Brajuha J; Singley K; Luck CC; Bass SB
    BMC Cancer; 2024 Apr; 24(1):412. PubMed ID: 38566032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivering on the promise of precision cancer medicine.
    Berger MF; Van Allen EM
    Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
    [No Abstract]   [Full Text] [Related]  

  • 6. Precision medicine in oncology: New practice models and roles for oncology pharmacists.
    Walko C; Kiel PJ; Kolesar J
    Am J Health Syst Pharm; 2016 Dec; 73(23):1935-1942. PubMed ID: 27864201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Somatic and Germline Variant Interpretation in Hereditary Cancer Genes.
    Moody EW; Vagher J; Espinel W; Goldgar D; Hagerty KJ; Gammon A
    JCO Precis Oncol; 2019 Dec; 3():1-8. PubMed ID: 35100725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Somatic" Tumor Genomic Profiling and Potential Germline Implications: Ethical Considerations for Children with Cancer.
    Knapp E
    J Law Med Ethics; 2020 Dec; 48(4):778-783. PubMed ID: 33404327
    [No Abstract]   [Full Text] [Related]  

  • 10. Integration of Genomic Profiling and Organoid Development in Precision Oncology.
    Yoon H; Lee S
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologists' Perceptions of Tumor Genomic Profiling and the Communication of Test Results and Risks.
    Hall MJ; D'Avanzo P; Chertock Y; Brajuha J; Bass SB
    Public Health Genomics; 2021; 24(5-6):304-309. PubMed ID: 34325422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advancements and Innovations in Pediatric Precision Oncology.
    Mangum R; Lin FY; Parsons DW
    J Pediatr Hematol Oncol; 2024 Jul; 46(5):262-271. PubMed ID: 38857189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal Genomic Testing: The next step in oncological decision-making or a dead end street?
    Holch JW; Metzeler KH; Jung A; Riedmann K; Jost PJ; Weichert W; Kirchner T; Heinemann V; Westphalen CB
    Eur J Cancer; 2017 Sep; 82():72-79. PubMed ID: 28648701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Medicine Takes the Stage, Again!
    Tempero M
    J Natl Compr Canc Netw; 2018 Jul; 16(7):795. PubMed ID: 30006420
    [No Abstract]   [Full Text] [Related]  

  • 15. Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.
    Mandal R; Chan TA
    Cancer Discov; 2016 Jul; 6(7):703-13. PubMed ID: 27107038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision Oncology Decision Support: Current Approaches and Strategies for the Future.
    Kurnit KC; Dumbrava EEI; Litzenburger B; Khotskaya YB; Johnson AM; Yap TA; Rodon J; Zeng J; Shufean MA; Bailey AM; Sánchez NS; Holla V; Mendelsohn J; Shaw KM; Bernstam EV; Mills GB; Meric-Bernstam F
    Clin Cancer Res; 2018 Jun; 24(12):2719-2731. PubMed ID: 29420224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision Cancer Medicine 2.0-Oncology in the postgenomic era.
    Masina R; Caldas C
    Mol Oncol; 2024 Sep; 18(9):2065-2069. PubMed ID: 39109701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision oncology: Charting a path forward to broader deployment of genomic profiling.
    Schram AM; Berger MF; Hyman DM
    PLoS Med; 2017 Feb; 14(2):e1002242. PubMed ID: 28222135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician interpretation of genomic test results and treatment selection.
    Brusco LL; Wathoo C; Mills Shaw KR; Holla VR; Bailey AM; Johnson AM; Khotskaya YB; Litzenburger BC; Sanchez NS; Zeng J; Bernstam EV; Eng C; Kee BK; Amaria RN; Routbort MJ; Mills GB; Mendelsohn J; Meric-Bernstam F
    Cancer; 2018 Mar; 124(5):966-972. PubMed ID: 29165790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic Profiling.
    Hamilton JG; Shuk E; Genoff MC; Rodríguez VM; Hay JL; Offit K; Robson ME
    J Oncol Pract; 2017 Jul; 13(7):e590-e601. PubMed ID: 28628391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.